PSYENCE BIOMEDICAL (PBMWW) Stock Price, News & Analysis
Company Description
PBMWW has gained 15.0% over the past year. Shares last traded at $0.0344.
For FY2025, PSYENCE BIOMEDICAL reported net income of $1.0M.
This page collects what Stock Titan holds for PBMWW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PSYENCE BIOMEDICAL (PBMWW) last closed at $0.0344. Over the past 12 months, PBMWW has gained 15.0%.
Latest News
SEC Filings
PSYENCE BIOMEDICAL has filed 5 recent SEC filings, including 2 Form 6-K, 1 Form 20-F, 1 Form SCHEDULE 13G/A, 1 Form SCHEDULE 13D. The most recent filing was submitted on June 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PBMWW SEC filings →
Financial Highlights
net income was $1.0M. The company generated -$3.7M in operating cash flow.
Upcoming Events
Short Interest History
Short interest in PSYENCE BIOMEDICAL (PBMWW) currently stands at 13.5 thousand shares, up 0.6% from the previous reporting period. Since August 2025, short interest has decreased by 65.3%. The 7.6 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for PSYENCE BIOMEDICAL (PBMWW) currently stands at 7.6 days, up 657% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 600.9% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.6 days.